Modified SALT Score for Alopecia Areata

• Status: Recruiting
• Trial end date: 2020-08-01
• Target enrollment: 0
• Participant gender: All

Summary

Patchy Alopecia areata was treated by intralesional steroids for 3 months and was evaluated by percentage of involvement, mSALT score and dermoscopy.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Kasr El Aini Hospital
• Treatments: Triamcinolone; Triamcinolone Acetonide; Triamcinolone diacetate; Triamcinolone hexacetonide

Criteria

Inclusion Criteria:

• localized scalp AA ( 2 patches and ≤50% scalp involvement , duration more than 6 months) • patients who did not receive any medication for at least 2 months before starting the study and those who agreed to join the study and signed written consent.

Exclusion Criteria:

• • pregnant, and lactating females

• Alopecia totalis or universalis or ophiasis or cicatritial alopecia

• Usage of systemic treatment of alopecia areata 2 months prior to the study.

• Any scalp lesion within the treated area

• Bleeding diathesis, severe anemia or platelet disorders

• Medical conditions such as autoimmune diseases.